Latest Antipsychotic Stories
Parker Waichman LLP, experienced personal injury lawyers who have represented thousands of clients in lawsuits involving defective drugs, comments on a new study published in JAMA Psychiatry revealing
CORAL SPRINGS, Florida, April 9, 2015 /PRNewswire/ -- According to a recent article [http://blogs.wsj.com/pharmalot/2014/09/29/high-prices-for-orphan-drug-can-be-sustained-a-payer-survey-shows
Researchers from The Children's Hospital of Philadelphia's PolicyLab Say Prescribing Practices Need to Include Thoughtful Risk/Benefit Consideration PHILADELPHIA, April 6, 2015 /PRNewswire-USNewswire/
Bernstein Liebhard LLP is representing numerous plaintiffs who have filed Risperdal lawsuits in the Pennsylvania litigation, all of whom allegedly developed gynecomastia (male breast growth) due
Results served as basis for regulatory filing with U.S.
Citizens Commission on Human Rights (CCHR), a leading mental health watchdog, announces its support for newly introduced legislation in the state of California with its latest press release, applauding
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
- Treatment for Major Depressive Disorder (MDD) in Adults- DUBLIN, March 16, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced the U.S.
- First atypical antipsychotic to be approved for pediatric patients with bipolar I disorder in the last five years - DUBLIN, March 13, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced
The Firm is representing numerous clients in Risperdal lawsuits that have been filed in the Pennsylvania mass tort proceeding, all of whom allegedly developed gynecomastia due to treatment with
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.